Viewing Study NCT01903135


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-03-09 @ 4:05 AM
Study NCT ID: NCT01903135
Status: COMPLETED
Last Update Posted: 2017-02-01
First Post: 2013-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prevalence of Obesity Hypoventilation Syndrome
Sponsor: AGIR à Dom
Organization:

Study Overview

Official Title: Prevalence of Obesity Hypoventilation Syndrome in Subjects With Obesity Referred to Clinical (Medical Analysis) Laboratories for Regular Follow-up
Status: COMPLETED
Status Verified Date: 2015-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: BIO-OHS
Brief Summary: Rationale of the "BIO-OHS" study (Prevalence of Obesity Hypoventilation Syndrome):

The overall prevalence of Obesity Hypoventilation Syndrome (OHS) has never been directly assessed in the general population. Actually, this prevalence has been assessed in patients referred to sleep clinics with a potential diagnosis of sleep-disordered breathing or in patients already diagnosed with sleep apnea. The purpose of this study is to determine the prevalence of Obesity Hypoventilation syndrome in obese patients referred to clinical laboratories for regular follow-up medical analysis.
Detailed Description: No additional description

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2013-A00744-41 OTHER ANSM View